Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000012

Chief Financial Officer sold 10,000 shares at an average $333.63 ($3,336,322)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-11 Exercise or conversion : show line 1 in the form +10,000 $106.59 $1,065,900 19,137 D
2021-01-11 Sale : show line 2 in the form −400 $328.68 $131,472 18,737 D
2021-01-11 Sale : show line 3 in the form −400 $330.27 $132,106 18,337 D
2021-01-11 Sale : show line 4 in the form −700 $331.61 $232,127 17,637 D
2021-01-11 Sale : show line 5 in the form −2,501 $333.23 $833,415 15,136 D
2021-01-11 Sale : show line 6 in the form −3,990 $334.39 $1,334,219 11,146 D
2021-01-11 Sale : show line 7 in the form −2,009 $334.98 $672,983 9,137 D
Open-market sales · 10,000 sh · avg $333.63 · $3,336,322

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-11 Exercise or conversion : show line 8 in the form Stock Options (Right to Buy) −10,000 49,942 D
Loading xslF345X03/edgar.xml…